Stock Ratings / Consumer Discretionary / POM / financials

YJ (30) BQ (34) TKLF (40) WBUY (24) ⌘ Pro Terminal →

POMDOCTOR LIMITED (Class A) (POM) Revenue-to-Profit Sankey Flow & SEC XBRL Financials

$1.54 -22.61% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $1.47

POMDOCTOR LIMITED (Class A) (POM) carries a Roarable Rating of D- (Sell) with 37/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record Warning: Scores below 50 (37/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows →

ROARABLE D- • RED ALERT Cap $5.5M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on POM Below — or Connect Your Own ChatGPT / Claude

🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is POM stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

▼

As of 2026-11-02, POMDOCTOR LIMITED (Class A) (NASDAQ: POM) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 37/100 at a spot price of $1.54 (-22.61% 1D, market cap $5.5M). Pillar breakdown: Fundamental Cash Engine 5/20, Institutional 13F & Options Flow 9/20, Executive Insider Alignment 10/20, FRED Macro Regime Fit 8/20, and SEC Balance-Sheet Forensics 5/20. Across 1011 tracked Consumer Discretionary issuers, POM ranks #794 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief

🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does POM compare to YJ and BQ in the Consumer Discretionary sector?

▼

Within the Consumer Discretionary sector (Other Specialty Stores), POM carries a Roarable D- (37/100 RQD), trailing P/E of N/A, gross margin of 13.1%, and ROIC of -35.0%. By comparison, YJ (Yunji Inc. American Depository Shares) holds a E grade (30/100 RQD, P/E N/A, ROIC -13.7%, cap $6.1M) and BQ (Boqii Holding Limited (Class A)) posts a E grade (34/100 RQD, P/E N/A, ROIC —, cap $3.9M). Among the 5-stock peer group, TKLF leads on earnings multiple (11.9x) while YJ leads on capital efficiency (-13.7% ROIC).

✓ Pre-computed one-to-many AI Quant brief

🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for POM?

▼

Per POM's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001877971), POMDOCTOR LIMITED (Class A) generated $57.2M in revenue, $0 in net income, and -$21.4M in free cash flow against $15.4M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Consumer Discretionary with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief

🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $1.47 (-4.26%)🧬 Disciplined Float (+0.72% YoY Shares)⚙️ Cash Engine: 5/20 (E) • 0% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record Warning: Scores below 50 (37/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows (-8.1% avg 90D alpha vs SPY • 29.0% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERRED ALERT • D-

3-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw E · Rk D

Each axis scored 0–20

12M PRICE TARGET CONE-9.7% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for POM)Realized 20D OHLCV Swing Band: ±12.5%

Deterministic 5-Pillar Attribution (37/100 Composite)

🔍 WHY POM SCORES 37/100 (D-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: SEC 10-K Forensic Risk+10/20 pts (27% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 1/9

▲ #2 Bullish Driver: Whale & Options Positioning+9/20 pts (24% of score)

20D Institutional Volume Accumulation (±12.5% realized swing band)

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution5/20 pts (-15 pt drag)

Disciplined Float (+0.72% YoY Shares) & executive Form 4 sales trim 15 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade E$0.62-14.5% Next Q

Q2 (-2Q)

Grade E$0.53+113.2% Next Q

Q3 (-1Q)

Grade E$1.13+36.3% Next Q

Current

Grade D-$1.54-8.1% Hist 90D α

Trajectory: E (29) → D- (37)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a POM Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While POM currently carries a cautious 37/100 (D-) rating due to Insider Conviction & Share Dilution (5/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Consumer Discretionary with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($1.00) and Max Pain ($1.62) forces dealer call-delta covering toward $121.53.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Disciplined Float (+0.72% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $POM• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “POM Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 37%NO 63%Trade / Inspect Odds →

VISUAL REVENUE-TO-PROFIT SANKEY WATERFALL • FY 2025 (10-K)

How POM Turns Every Dollar of Sales Into Real Bottom-Line Profit

Free Cash Flow:$0 (0% FCF Margin)

Multi-Year SEC EDGAR XBRL Revenue, Net Profit & Free Cash Flow Trajectory

■ Revenue■ Net Profit■ Free Cash Flow

FY25

Rev $57.2M

Fiscal Year	Revenue	Gross Margin	Op Margin	Net Profit	Free Cash Flow	ROIC %
FY 2025	$57.2M	13.1%	-29.7%	$0	-$21.4M	-45%

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring POM)

✓Walkthrough of POM's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

POM // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -77.49%📐 HORIZONTAL RANGE

2026-11-02O $1.80H $1.99L $1.54C $1.54VOL 1.66M

RES: $3.15SUP: $0.40SMA50: $1.00SMA200: $2.91

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

POM Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 POM Butterfly Map → + Track POM →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on POM today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for POM. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for POM today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (POM)

Consumer Discretionary Rank #794 of 1011 ⚔️ YJ vs POM Full Matrix →

1. Head-to-Head Consumer Discretionary Peer Comparison (POM vs. YJ, BQ, TKLF, WBUY)

Industry: Other Specialty Stores (42 Tracked Issuers)

Across 1011 tracked Consumer Discretionary securities in the Roarable RQD universe, POMDOCTOR LIMITED (Class A) (POM) ranks #794 by composite RQD confidence (37/100, grade D-) and #964 by equity capitalization ($5.5M). Within this direct 5-issuer industry benchmark cohort, TKLF leads on earnings valuation at 11.9x trailing P/E, while YJ leads on capital efficiency and profitability with -13.7% ROIC and 44.4% gross margin. TKLF currently holds the highest overall quantitative score in the immediate peer group at 40/100 (D-) compared with POM at 37/100 (D-).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
POM ACTIVE POMDOCTOR LIMITED (Class A)	D-	37/100	—	13.1%	-35.0%	-22.61%	$5.5M	Benchmark Subject
YJ Yunji Inc. American Depository Shares	E	30/100	—	44.4%	-13.7%	-3.25%	$6.1M	/yj-vs-pom →
BQ Boqii Holding Limited (Class A)	E	34/100	—	26.3%	—	-3.29%	$3.9M	/bq-vs-pom →
TKLF Tokyo Lifestyle Co. Ltd.	D-	40/100	11.9x	—	—	-1.96%	$8.5M	/tklf-vs-pom →
WBUY WEBUY GLOBAL LTD. (Class A)	E	24/100	—	12.0%	-35.0%	-10.49%	$3.3M	/wbuy-vs-pom →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2025–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001877971

In its most recent audited fiscal period (FY2025, filed 2025-12-31), POMDOCTOR LIMITED (Class A) (POM) reported GAAP revenue of $57.2M , GAAP net income of $0, operating cash flow of -$21.2M, and free cash flow of -$21.4M . On the balance sheet, POM closed FY2025 with $15.4M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 1/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$57.2M	$0	-$21.2M	-$21.4M	$15.4M	—

3. POM Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is POM stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

How does POM compare to YJ and BQ in the Consumer Discretionary sector?

What are the biggest fundamental strengths and SEC risk factors for POM?

Where is POM trading relative to its 50-day, 200-day, and 52-week technical levels?

POM last traded at $1.54 (-22.61% on volume of 723,684 shares), positioning the stock +54.00% above its 50-day simple moving average ($1.00) and -47.08% below its 200-day simple moving average ($2.91). Across its 52-week range of $0.43 to $115.74, POM sits at the 1.0% percentile with a 14-day RSI of 58.6 (BULLISH MOMENTUM) and an implied next-earnings move of ±12.5% ($1.35 to $1.73).

POM Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

How profitable is POMDOCTOR LIMITED (Class A) (POM)?

In FY 2025 (10-K), POM converted $57.2M of revenue into a 13.1% gross margin, 0% operating margin, and $0 in free cash flow (0% FCF margin).

Direct Sub-Reports: POM RQD Cockpit POM 12M Forecast POM Earnings & Move POM Dividends & DRIP POM Insiders & 13F POM Whale Options POM Profit Sankey POM News & Why

ROARABLE RATING BRIEF • RQD 37/100 (D-) ✓ STAGE-C NUMBER FIREWALL VERIFIED

POM — POMDOCTOR LIMITED (Class A): What the Facts Mean to a Prospective Investor

Engine: anthropic/claude-haiku-5.5

As of: 2026-11-02T14:20:27Z

Roarable Rating Brief: What This Means to a Prospective Investor

Per the Roarable RQD rating, POM scores 37 out of 100 with a letter grade of D- and a verdict of "Roarable Sell — Vulnerable Balance Sheet & Flow." The fundamental cash engine pillar scores 5 of 20, reflecting ROIC of -35% and an FCF yield of 0%, which indicates the business is not currently generating returns on invested capital or free cash flow relative to its valuation. The whale 13F flow pillar scores 9 of 20 for institutional accumulation and options positioning, which is the second-weakest reading and suggests limited sponsorship from large holders. The insider conviction pillar scores 5 of 20 based on SEC Form 4 and Congressional PTR cluster flow, indicating weak insider signaling. The macro regime fit pillar scores 8 of 20 with a beta of 1.0 and sector sensitivity considered. The forensic balance sheet pillar scores 10 of 20, with an Altman Z-Score of 2.5, a Piotroski F-Score of 1/9, and Debt/Equity of 0.5. For a prospective investor, the upside case rests on any turnaround in cash generation, which the rating does not show yet; the valuation tradeoff is that the price of $1.99 is set against negative operating margin and zero net margin, leaving little earnings support; and the rating's weakest links (cash engine, insider conviction, and whale flow) are the signals that would need to improve before the thesis strengthens.

Financial Trend

Period	Revenue	Operating Income	Net Income	EPS	FCF	Cash	Debt
FY 2025	$57.2M	$-17.0M	$0.0M	N/A	$-21.4M	$1.4M	N/A

Per the SEC financials, FY 2025 (filed 2025-12-31) shows operating income of $-17.0M and free cash flow of $-21.4M, with net income at $0.0M. Per market data, gross margin is 13.1%, operating margin -29.7%, and net margin 0%, with ROIC of -35%. Per the Roarable RQD rating, the Altman Z-Score is 2.5, the Piotroski F-Score is 1/9, and Debt/Equity is 0.5. Cash of $1.4M is small relative to the negative free cash flow reported for the period.

Recent Catalysts & News Wire Analysis

Per the recent news feed, the dominant items are corporate and listing-related: announcements of termination of the ADR program with Class A shares trading on Nasdaq, receipt of a Nasdaq Staff Delisting Determination, and a 10-for-1 share consolidation. Each is flagged YELLOW. Market-action items note a pullback amid volatility and a 15.88% decline to $0.53 with a $0.50 support level referenced. Risk watch items are the delisting determination and the share consolidation. The Butterfly supply-chain graph reports sector Consumer Discretionary, industry Other Specialty Stores, supply chain "NONE," with no butterfly links and no proprietary signals.

Open Questions

What products and customers generate the $57.2M in FY 2025 revenue, and how is it earned?
What is the debt amount underlying the Debt/Equity ratio of 0.5, given that the debt field is N/A?
What is the reason for the 10-for-1 share consolidation and the Nasdaq Staff Delisting Determination, and what compliance deadline applies?
Why is EPS N/A and P/E unavailable, and what is the company's earnings trajectory?
Who are the institutional and insider holders, given that the holders section is empty?

POM Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for POMDOCTOR LIMITED (Class A) (POM) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to POM Debate Forum (3) ↓

🟡 MARKET WIRE Yahoo Finance • 12h ago

POMDOCTOR LIMITED Announces the Termination of Its ADR Program and Trade Class A Ordinary Shares on Nasdaq

Yahoo Finance report covering POMDOCTOR LIMITED (Class A) (POM) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE TradingView • 15h ago

POMDOCTOR LIMITED Estimates – NASDAQ:POM

TradingView report covering POMDOCTOR LIMITED (Class A) (POM) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Yahoo Finance • 18h ago

POMDOCTOR LIMITED Announces Receipt of Nasdaq Staff Delisting Determination

Yahoo Finance report covering POMDOCTOR LIMITED (Class A) (POM) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE TradingView • 21h ago

POMDOCTOR LIMITED Ends ADRs; 10-for-1 Share Consolidation

TradingView report covering POMDOCTOR LIMITED (Class A) (POM) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE StocksToTrade • 1d ago

POM Stock Pulls Back As Volatility Grips Short-Term Traders

StocksToTrade report covering POMDOCTOR LIMITED (Class A) (POM) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE https://www.dars.gov.et/ • 1d ago

Pomdoctor (POM) Slides 15.88% to $0.53 as $0.50 Support Comes Into Focus - Sentiment Divergence

https://www.dars.gov.et/ report covering POMDOCTOR LIMITED (Class A) (POM) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE StocksToTrade • 1d ago

POM Stock Explodes On Volume As Traders Hunt Volatility

StocksToTrade report covering POMDOCTOR LIMITED (Class A) (POM) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE StocksToTrade • 1d ago

POMDOCTOR LIMITED Rockets On Momentum As Traders Pile In

StocksToTrade report covering POMDOCTOR LIMITED (Class A) (POM) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

POM Bull vs. Bear Conversation Board — What's Your Call at $1.54?

🐂 33% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON POM 🐻 67% BEARISH CONVICTION

RO RoarDesk_Moderator Roarable Research Desk 🐻 BEARISH 🎯 Target: $1.75 (-12.1%)

📌 Pinned Debate

🔥 Official Bull vs. Bear Debate: Is POM (D- • RQD 37/100) a Buy at $1.99?

Welcome to the POM (POMDOCTOR LIMITED (Class A)) Roar Pit. Current RQD Composite is 37/100 (Roarable Sell — Vulnerable Balance Sheet & Flow) in Other Specialty Stores. Bulls point to operating leverage and sector positioning, while bears focus on macro rate sensitivity and margin execution. Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.

SK SkepticalCFA Forensic Accounting Watch 🐻 BEARISH 🎯 Target: $1.55 (-22.1%)

Spot @ $1.99

Pump the brakes on POM — check the valuation vs. margin headwinds

Everyone in here is repeating the bull case on POM, but look at what you are paying: current EV/EBITDA multiples with 13.1% gross margins. Unless POMDOCTOR LIMITED (Class A) expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.

CA CashFlowKing Verified K Arena Trader 🐂 BULLISH 🎯 Target: $2.39 (+20.1%)

Spot @ $1.99

POM cash flow & RQD setup is being underpriced by the Street here

Looking at the 5-pillar RQD breakdown on POM, the market is fixating on short-term headline noise in Other Specialty Stores and ignoring the balance sheet and cash flow trajectory. At $1.99 (52-wk range $0.43 - $115.74), any beat on forward guidance forces shorts and underweight funds to chase.